Agradis will focus on developing and commercializing products to improve crop production efficiency using new advances in genomics and plant breeding.
The new company has also closed a $20m Series A financing round, that helps to establish the company infrastructure and to support product development and commercialization.
Agradis is combining science and technology platforms of SGI with the agricultural business commercialization expertise of Plenus to solve some of these societal issues.
Agradis is initially focusing on two key areas: producing superior crops through advances in genomics and developing crop protection and plant growth enhancing products using beneficial, plant-associated microorganisms.
The first two crops that Agradis will concentrate on are castor and sweet sorghum.
Synthetic Genomics is engaged in developing and applying genomic-driven commercial solutions to markets including biofuels, biochemicals, and new bio-based food products.
US-based Plenus is an investing and management company with experience in a variety of business areas including agribusiness.
